EMST for Swallowing Disorders in Head and Neck Cancer Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a special breathing exercise, called expiratory muscle strength training (EMST), can help people with head and neck cancer maintain safe swallowing during treatment. Participants will use either a regular EMST device or a modified version that requires no effort. The researchers aim to determine if the active device helps keep swallowing muscles functioning well. The trial seeks individuals recently diagnosed with head or neck cancer who are beginning radiation or chemotherapy and can use the EMST device. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance quality of life during cancer treatment.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that EMST is safe for swallowing disorders in head and neck cancer patients?
Research shows that expiratory muscle strength training (EMST) is generally safe for people with head and neck cancer. Studies have found that EMST strengthens swallowing muscles, improving swallowing for some patients.
In one study, seven out of 21 patients reported feeling safer after completing EMST, indicating a positive response to the treatment. No major reports of serious side effects from EMST have emerged.
Overall, the treatment is well-tolerated, with no significant negative effects reported in the studies. While more research is always beneficial, current evidence suggests EMST is safe for people with head and neck cancer.12345Why are researchers excited about this trial?
Researchers are excited about the EMST (Expiratory Muscle Strength Training) treatment for swallowing disorders in head and neck cancer patients because it offers a non-invasive approach that strengthens the muscles involved in swallowing. Unlike traditional treatments like surgery or medication, EMST uses a simple device that patients can use at home to improve their swallowing function by targeting and enhancing expiratory muscle strength. This method is unique because it empowers patients to take an active role in their rehabilitation, potentially leading to faster and more effective improvements in their ability to swallow safely. The treatment also minimizes the need for more invasive procedures, which can be a significant advantage for those recovering from cancer treatment.
What evidence suggests that EMST is effective for swallowing disorders in head and neck cancer patients?
Research has shown that expiratory muscle strength training (EMST) strengthens the muscles used for swallowing. In this trial, participants will be randomized into two groups: one receiving Active EMST + Standard Care and the other receiving Sham EMST + Standard Care. Studies have found that this training improves swallowing, which is crucial for head and neck cancer patients undergoing radiation therapy. Evidence suggests that EMST increases the strength of exhalation, aiding in safer swallowing. However, some reviews have reported mixed results on its effect on specific swallowing measures. Overall, EMST has effectively made swallowing safer and more efficient, offering hope for patients with swallowing difficulties.23567
Who Is on the Research Team?
Barbara Pauloski
Principal Investigator
University of Wisconsin, Milwaukee
Are You a Good Fit for This Trial?
This trial is for adults over 18 with a new diagnosis of cancer in the oral cavity, oropharynx, hypopharynx, or larynx who are about to undergo radiation therapy with or without chemotherapy. Participants must be able to use and maintain a seal on the EMST150 device. Those with prior head and neck surgery (except neck dissection), previous radiotherapy, non-HNCA related swallowing issues, progressive neurological conditions affecting muscle strength, or certain primary cancers are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants are evaluated prior to initiation of cancer treatment, including measurement of maximum expiratory pressure (MEP), a videofluoroscopic swallow study (VFSS), and administration of swallow-related quality of life (QOL) questionnaires
Treatment
Participants undergo an 8-week program of either Active or Sham Expiratory Muscle Strength Training (EMST) coincident with RT/CRT, with assessments at 4 weeks and 8 weeks
Follow-up
Participants are monitored for changes in swallowing function and quality of life post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- EMST
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Milwaukee
Lead Sponsor
Froedtert Hospital
Collaborator
Medical College of Wisconsin
Collaborator